Ovintiv (NYSE:OVV) Issues Quarterly Earnings Results

Ovintiv (NYSE:OVVGet Free Report) issued its quarterly earnings results on Monday. The company reported $2.00 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.85 by $0.15, Zacks reports. Ovintiv had a net margin of 13.94% and a return on equity of 12.00%.

Ovintiv Price Performance

Shares of Ovintiv stock traded up $1.24 on Monday, reaching $59.07. 5,237,169 shares of the stock were exchanged, compared to its average volume of 4,690,614. The firm’s 50 day moving average is $56.34 and its 200-day moving average is $46.22. Ovintiv has a one year low of $34.88 and a one year high of $63.46. The company has a debt-to-equity ratio of 0.39, a quick ratio of 0.54 and a current ratio of 0.54. The firm has a market cap of $16.74 billion, a PE ratio of 12.20, a P/E/G ratio of 1.94 and a beta of 0.57.

Ovintiv Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 31st. Stockholders of record on Friday, March 13th were issued a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a dividend yield of 2.0%. The ex-dividend date of this dividend was Friday, March 13th. Ovintiv’s dividend payout ratio is 24.79%.

Analysts Set New Price Targets

OVV has been the subject of a number of analyst reports. Morgan Stanley assumed coverage on shares of Ovintiv in a research report on Friday, March 27th. They issued an “equal weight” rating and a $68.00 price objective for the company. Zacks Research raised shares of Ovintiv from a “strong sell” rating to a “hold” rating in a report on Tuesday, March 3rd. Barclays lifted their target price on shares of Ovintiv from $58.00 to $62.00 and gave the stock an “overweight” rating in a report on Monday, March 16th. The Goldman Sachs Group lifted their target price on shares of Ovintiv from $49.00 to $62.00 and gave the stock a “buy” rating in a report on Wednesday, March 11th. Finally, Scotiabank lifted their target price on shares of Ovintiv from $58.00 to $65.00 and gave the stock a “sector outperform” rating in a report on Thursday, March 19th. Fifteen investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $60.42.

Read Our Latest Report on OVV

Insider Buying and Selling

In other news, EVP Meghan Nicole Eilers sold 11,582 shares of the company’s stock in a transaction that occurred on Friday, March 13th. The shares were sold at an average price of $54.78, for a total transaction of $634,461.96. Following the completion of the sale, the executive vice president owned 54,092 shares of the company’s stock, valued at approximately $2,963,159.76. This represents a 17.64% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Howard John Mayson sold 5,000 shares of the company’s stock in a transaction that occurred on Tuesday, March 3rd. The stock was sold at an average price of $52.39, for a total transaction of $261,950.00. Following the sale, the director directly owned 45,780 shares of the company’s stock, valued at approximately $2,398,414.20. This trade represents a 9.85% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Corporate insiders own 0.85% of the company’s stock.

Institutional Trading of Ovintiv

Institutional investors and hedge funds have recently made changes to their positions in the company. Los Angeles Capital Management LLC bought a new stake in shares of Ovintiv during the 4th quarter worth approximately $46,000. Advisory Services Network LLC acquired a new position in Ovintiv during the 3rd quarter worth approximately $58,000. CIBC Private Wealth Group LLC increased its position in Ovintiv by 258.2% during the 3rd quarter. CIBC Private Wealth Group LLC now owns 1,576 shares of the company’s stock worth $64,000 after purchasing an additional 1,136 shares in the last quarter. Geneos Wealth Management Inc. increased its position in Ovintiv by 47.5% during the 1st quarter. Geneos Wealth Management Inc. now owns 1,830 shares of the company’s stock worth $78,000 after purchasing an additional 589 shares in the last quarter. Finally, Parkside Financial Bank & Trust increased its position in Ovintiv by 30.4% during the 4th quarter. Parkside Financial Bank & Trust now owns 2,121 shares of the company’s stock worth $83,000 after purchasing an additional 495 shares in the last quarter. Institutional investors own 83.81% of the company’s stock.

About Ovintiv

(Get Free Report)

Ovintiv Inc is a North American energy company focused on the exploration, development and production of oil, natural gas and natural gas liquids. Formerly known as Encana Corporation, the company rebranded as Ovintiv in January 2020 and established its headquarters in Denver, Colorado. Ovintiv’s upstream portfolio spans multiple unconventional resource plays, reflecting a strategy centered on high-return projects and disciplined capital allocation.

The company’s core business activities include the acquisition and development of acreage in major shale basins across the United States and Canada.

Further Reading

Earnings History for Ovintiv (NYSE:OVV)

Receive News & Ratings for Ovintiv Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ovintiv and related companies with MarketBeat.com's FREE daily email newsletter.